Synonym:
4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide,
CJ-016377,
CP-598107,
Celecoxib,
PF-00345549,
PHA-00846533,
SC-58635,
YM-177
Properties:
Related Categories |
Additional Standards,
Analytical Standards,
Analytical/Chromatography,
Chromatography,
Pharmaceutical Secondary Standards,
|
grade
|
certified reference material
|
|
pharmaceutical secondary standard
|
InChI Key
|
RZEKVGVHFLEQIL-UHFFFAOYSA-N
|
packaging
|
pkg of 1 g
|
pharmacopeia traceability
|
USP
|
|
traceable to PhEur Y0001445
|
Description:
Analysis Note
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
General description
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Other Notes
This product was designed, produced and verified for accuracy and stability in accordance with ISO/IEC 17025:2005 (AClass Cert AT-1467), ISO GUIDES 34:2009 (AClass Cert AR-1470).
Biochem/physiol Actions
Celecoxib is a non-steroidal, anti-inflammatory drug (NSAID) and a cyclooxygenase-2 (COX-2) selective inhibitor. Celecoxib is at least 10-20 times more selective for COX-2 over COX-1.
Footnote
To see an example of a Certificate of Analysis for this material enter LRAA6299 in the slot below. This is an example certificate only and may not be the lot that you receive.
Safety:
Symbol
GHS08
Precautionary statements
P201-P308 + P313